Canada Addresses Diversity In Clinical Trials With New Rule For Drug Filings
Health Canada wants drug sponsors to start answering questions relating to disaggregated data for sex, age and race.
Health Canada wants drug sponsors to start answering questions relating to disaggregated data for sex, age and race.